Cargando…

Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania

BACKGROUND: Within the context of combined interventions, malaria vaccine may provide additional value in malaria prevention. Stakeholders’ perspectives are thus critical for informed recommendation of the vaccine in Tanzania. This paper presents the views of stakeholders with regards to malaria vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mtenga, Sally, Kimweri, Angela, Romore, Idda, Ali, Ali, Exavery, Amon, Sicuri, Elisa, Tanner, Marcel, Abdulla, Salim, Lusingu, John, Kafuruki, Shubi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822277/
https://www.ncbi.nlm.nih.gov/pubmed/27048260
http://dx.doi.org/10.1186/s12936-016-1209-6
_version_ 1782425753151864832
author Mtenga, Sally
Kimweri, Angela
Romore, Idda
Ali, Ali
Exavery, Amon
Sicuri, Elisa
Tanner, Marcel
Abdulla, Salim
Lusingu, John
Kafuruki, Shubi
author_facet Mtenga, Sally
Kimweri, Angela
Romore, Idda
Ali, Ali
Exavery, Amon
Sicuri, Elisa
Tanner, Marcel
Abdulla, Salim
Lusingu, John
Kafuruki, Shubi
author_sort Mtenga, Sally
collection PubMed
description BACKGROUND: Within the context of combined interventions, malaria vaccine may provide additional value in malaria prevention. Stakeholders’ perspectives are thus critical for informed recommendation of the vaccine in Tanzania. This paper presents the views of stakeholders with regards to malaria vaccine in 12 Tanzanian districts. METHODS: Quantitative and qualitative methods were employed. A structured questionnaire was administered to 2123 mothers of under five children. Forty-six in-depth interviews and 12 focus group discussions were conducted with teachers, religious leaders, community health workers, health care professionals, and scientists. Quantitative data analysis involved frequency distributions and cross tabulations using Chi square test to determine the association between malaria vaccine acceptability and independent variables. Qualitative data were analysed thematically. RESULTS: Overall, 84.2 % of the mothers had perfect acceptance of malaria vaccine. Acceptance varied significantly according to religion, occupation, tribe and region (p < 0.001). Ninety two percent reported that they will accept the malaria vaccine despite the need to continue using insecticide-treated nets (ITNs), while 88.4 % reported that they will accept malaria vaccine even if their children get malaria less often than non-vaccinated children. Qualitative results revealed that the positive opinions towards malaria vaccine were due to a need for additional malaria prevention strategies and expectations that the vaccine will reduce visits to the health facility, deaths, malaria episodes and treatment-related expenses. Vaccine related questions included its side effects, efficacy, protective duration, composition, interaction with other medications, provision schedule, availability to the pregnant women, mode of administration (oral or injection?) and whether a child born of HIV virus or with a chronic illness will be eligible for the vaccine? CONCLUSION: Stakeholders had high acceptance and positive opinions towards the combined use of the anticipated malaria vaccine and ITNs, and that their acceptance remains high even when the vaccine may not provide full protection, this is a crucial finding for malaria vaccine policy decisions in Tanzania. An inclusive communication strategy should be designed to address the stakeholders’ questions through a process that should engage and be implemented by communities and health care professionals. Social cultural aspects associated with vaccine acceptance should be integrated in the communication strategy.
format Online
Article
Text
id pubmed-4822277
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48222772016-04-07 Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania Mtenga, Sally Kimweri, Angela Romore, Idda Ali, Ali Exavery, Amon Sicuri, Elisa Tanner, Marcel Abdulla, Salim Lusingu, John Kafuruki, Shubi Malar J Research BACKGROUND: Within the context of combined interventions, malaria vaccine may provide additional value in malaria prevention. Stakeholders’ perspectives are thus critical for informed recommendation of the vaccine in Tanzania. This paper presents the views of stakeholders with regards to malaria vaccine in 12 Tanzanian districts. METHODS: Quantitative and qualitative methods were employed. A structured questionnaire was administered to 2123 mothers of under five children. Forty-six in-depth interviews and 12 focus group discussions were conducted with teachers, religious leaders, community health workers, health care professionals, and scientists. Quantitative data analysis involved frequency distributions and cross tabulations using Chi square test to determine the association between malaria vaccine acceptability and independent variables. Qualitative data were analysed thematically. RESULTS: Overall, 84.2 % of the mothers had perfect acceptance of malaria vaccine. Acceptance varied significantly according to religion, occupation, tribe and region (p < 0.001). Ninety two percent reported that they will accept the malaria vaccine despite the need to continue using insecticide-treated nets (ITNs), while 88.4 % reported that they will accept malaria vaccine even if their children get malaria less often than non-vaccinated children. Qualitative results revealed that the positive opinions towards malaria vaccine were due to a need for additional malaria prevention strategies and expectations that the vaccine will reduce visits to the health facility, deaths, malaria episodes and treatment-related expenses. Vaccine related questions included its side effects, efficacy, protective duration, composition, interaction with other medications, provision schedule, availability to the pregnant women, mode of administration (oral or injection?) and whether a child born of HIV virus or with a chronic illness will be eligible for the vaccine? CONCLUSION: Stakeholders had high acceptance and positive opinions towards the combined use of the anticipated malaria vaccine and ITNs, and that their acceptance remains high even when the vaccine may not provide full protection, this is a crucial finding for malaria vaccine policy decisions in Tanzania. An inclusive communication strategy should be designed to address the stakeholders’ questions through a process that should engage and be implemented by communities and health care professionals. Social cultural aspects associated with vaccine acceptance should be integrated in the communication strategy. BioMed Central 2016-04-05 /pmc/articles/PMC4822277/ /pubmed/27048260 http://dx.doi.org/10.1186/s12936-016-1209-6 Text en © Mtenga et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mtenga, Sally
Kimweri, Angela
Romore, Idda
Ali, Ali
Exavery, Amon
Sicuri, Elisa
Tanner, Marcel
Abdulla, Salim
Lusingu, John
Kafuruki, Shubi
Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title_full Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title_fullStr Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title_full_unstemmed Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title_short Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania
title_sort stakeholders’ opinions and questions regarding the anticipated malaria vaccine in tanzania
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822277/
https://www.ncbi.nlm.nih.gov/pubmed/27048260
http://dx.doi.org/10.1186/s12936-016-1209-6
work_keys_str_mv AT mtengasally stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT kimweriangela stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT romoreidda stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT aliali stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT exaveryamon stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT sicurielisa stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT tannermarcel stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT abdullasalim stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT lusingujohn stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania
AT kafurukishubi stakeholdersopinionsandquestionsregardingtheanticipatedmalariavaccineintanzania